PriceTargets.com logo

Mountain Crest Acquisition Corp. II - MCAD Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.01 As of 04/25/2024 01:00 AM ET
+0 (0.00%)
Get New Mountain Crest Acquisition Corp. II Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MCAD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MCAD

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Mountain Crest Acquisition Corp. II in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.01.

This chart shows the closing price for MCAD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Mountain Crest Acquisition Corp. II. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/2/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/29/2021Lake Street CapitalInitiated CoverageBuy$19.00Low
(Data available from 4/26/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/29/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/29/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/26/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

Mountain Crest Acquisition Corp. II

Mountain Crest Acquisition Corp. II. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Read More

Today's Range

Now: $0.01
Low: $0.01
High: $0.02

50 Day Range

MA: $9.10
Low: $4.78
High: $10.97

52 Week Range

Now: $0.01
Low: $8.50
High: $12.99

Volume

547,883 shs

Average Volume

74,637 shs

Market Capitalization

$68.01 thousand

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Mountain Crest Acquisition Corp. II?

The following equities research analysts have issued reports on Mountain Crest Acquisition Corp. II in the last twelve months:
View the latest analyst ratings for MCAD.

What is the current price target for Mountain Crest Acquisition Corp. II?

0 Wall Street analysts have set twelve-month price targets for Mountain Crest Acquisition Corp. II in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Mountain Crest Acquisition Corp. II in the next year.
View the latest price targets for MCAD.

What is the current consensus analyst rating for Mountain Crest Acquisition Corp. II?

Mountain Crest Acquisition Corp. II currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MCAD.

What other companies compete with Mountain Crest Acquisition Corp. II?

Other companies that are similar to Mountain Crest Acquisition Corp. II include Ignyte Acquisition, Statera Biopharma, Bruush Oral Care, Humanigen and Scopus BioPharma. Learn More about companies similar to Mountain Crest Acquisition Corp. II.

How do I contact Mountain Crest Acquisition Corp. II's investor relations team?

Mountain Crest Acquisition Corp. II's physical mailing address is 311 WEST 43RD STREET 12TH FLOOR, NEW YORK NY, 10036. The company's listed phone number is 646-493-6558 and its investor relations email address is [email protected]. The official website for Mountain Crest Acquisition Corp. II is mcacquisition.com. Learn More about contacing Mountain Crest Acquisition Corp. II investor relations.